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ABSTRACT
Background: The Georgia Charitable Care Network (GCCN) is a non-profit organization whose primary mission is to foster
collaborative partnerships to deliver compassionate health care to low-income, uninsured individuals. Hypertension screening
and management is a service provide by 90+ clinics in the GCCN statewide.
Methods: With data from N=1661 patients who were screened and treated for hypertension at n=12 clinics in 2013, the
impact of hypertension management on blood pressure levels, the incidence of coronary heart disease (CHD) and stroke, and
utilization of emergency departments (EDs) were examined. The resulting changes in healthcare utilization were converted to
changes in healthcare costs and compared to the expenditures for clinics providing screening and treatment services to the
same population over a one-year period.
Results: Patients with an initial diagnosis of hypertension or prehypertension experienced average reductions of 10.27 mmHg
and 6.32 mmHg in systolic and diastolic blood pressure, respectively, during their follow-up visits. These changes were
associated with 32.0% and 44.3% reductions in the relative risk of CHD and stroke, respectively. The savings from this
reduction in blood pressure and avoided ED visits for 1661 hypertensive patients produced positive net benefits in 2013 US$,
of more than $400,000, with a benefit-cost ratio of 1.6.
Conclusions: For every dollar invested in GCCN clinics for hypertension screening and management, there is a benefit to the
healthcare system through reduced costs of $1.60. GCCN clinics are a cost-saving delivery model for underserved
communities with poor health status and high ED usage.
Keywords: hypertension, cost(s), benefit-cost analysis, return on investment, charitable care

Despite these efforts, it has been estimated that 20 million
individuals will remain uninsured after the ACA is fully
implemented (Chazin et al, 2010). In Georgia, where the
political leadership has decided to forego Medicaid
expansion, hundreds of thousands of citizens remain
uninsured, at a rate considerably higher than the national
average (Georgia Budget Policy Institute, 2015). Therefore,
clinics within GCCN will continue to be essential providers
of healthcare access to Georgia’s vulnerable populations.

INTRODUCTION
Charitable clinics have long worked at the local level to
address needs of the uninsured through a wide range of free
and nearly free primary healthcare services, often with the
goal to prevent and manage disease before patients require
emergency care or are hospitalized. These clinics deliver a
variety of services, including primary, preventive, and
specialty care, and provide an important safety net for lowincome, uninsured, and underserved populations in both
rural and urban communities. In Georgia, there are more
than 100 independent, not-for-profit charitable clinics and
hundreds of physicians, dentists, and other health care
professionals who provide charitable care throughout the
state. Each is dedicated to serving, through the GCCN,
many of the more than 1.8 million uninsured in Georgia
(Smith & Medalia, 2014).

A fundamental challenge faced by charitable clinics is to
demonstrate to funders that they have a clinical and
economic impact within their communities. Clinics often
lack the resources to collect patient outcome data over time
and the expertise to assess economic return on investment.
Because nonprofit organizations serving the under- and
uninsured have limited resources with which to deliver the
costly care associated with populations encountering
barriers to access (Bicki et al, 2013), it is necessary for these
health care clinics to understand and empirically evaluate
the economic impact of effectively delivering primary care
to their clinic population. Funders of these organizations,

At the federal level, the Affordable Care Act (ACA) was
passed, in part, to address the needs of the uninsured
through Medicaid expansion and federal health insurance
subsidies for individuals below 400% of the poverty line.
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such as local businesses and/or hospitals serving the same
community, may also ask for (or require) information on
how their resources are spent and the economic returns for
those resources expended. In this study, longitudinal data
provided by clinics were used to assess the economic impact
of treating and managing patients in the GCCN.

calendar year: a) annual operating expenditures; b) number
of unique patients served annually; c) number of patient
visits annually; d) number of hypertension screenings
performed; and e) for newly diagnosed hypertensive
patients, blood pressure at the time of screening and at a 1year follow-up. Eight clinics were excluded, as they were
not in operation for the entire year of 2013. Data on the
number of patients served and/or the number of patient
visits were received from n=53 clinics, or 61% of the
network. Annual operating costs or costs per visit were
obtained for n=18 clinics (21%); and data specific to
hypertension management was received from n=12 clinics
(14%). Locations of the clinics that provided detailed
patient-level data on hypertension management are shown in
Figure 1. They represent 12 of the 18 public health districts
across the state of Georgia. The clinics include: Bethesda
Community Clinic in Cherokee County, the Free Clinic of
Rome in Floyd County; Good News Clinics in Hall County;
Good Shepherd Clinic in Clayton County; Macon Volunteer
Clinic in Bibb County; Partnership Health Center in
Lowndes County; Physicians’ Care Clinic in DeKalb
County; Rock Springs Clinic in Lamar County; The Care
Place in Douglas County; Mercy Medical Clinic in Toombs
County; Gwinnett Community Clinic in Gwinnett County;
and the Athens Nurses Clinic in Clarke County.

GCCN Clinics
GCCN member clinics include both charitable and free
clinics, and the network is diverse in terms of size, model,
and scope of services provided. Charitable clinics are notfor-profit, community-based health centers that provide
services to uninsured, underserved, and vulnerable
populations. Most offer preventive services and fund their
operations through grants, patient fees, and donations.
Although charitable clinics may serve the publicly insured,
they do not receive enhanced reimbursements from
Medicaid. Patients may pay a flat rate or a fee based on a
sliding scale. Free clinics represent 63% of all GCCN
clinics and provide healthcare services at no cost to patients.
These clinics utilize a volunteer/staff model and provide a
range of medical, dental, pharmacy, optical, and behavioral
health services to economically disadvantaged individuals.
Free clinics restrict eligibility to the uninsured or individuals
with limited access to primary care, specialty care, or
pharmaceuticals. These clinics are often communitysupported and are funded primarily by private donations and
foundations. Most personnel at charitable and free clinics
are volunteers, including physicians, dentists, and other
specialty providers from private practices and hospitals.

Figure 1. Location of clinics providing data on HTN
patients

GCCN clinics, located in 90 of Georgia’s 159 counties,
provide various healthcare services: 46% provide dental or
vision services; 86% provide prescription assistance; 83%
provide health education; and 34% provide mental health
services. On average, clinics are open 20 hours per week
and receive 4200 hours of volunteer labor each year. Most
of the population served by GCCN clinics can be
characterized as the sick and the working poor. Most
patients are employed, and 80% have one or more chronic
illness requiring extensive and ongoing medical treatment,
coordination of care, and patient education.
Since hypertension is the most common diagnosis for
patients served by GCCN clinics, this study focuses on the
cost-savings to the healthcare system for the identification,
treatment, and management of hypertension. To our
knowledge, this is the first economic evaluation to assess
the cost-savings from lowering blood pressure and reducing
emergency department (ED) usage through the treatment of
hypertensive patients in a free clinic setting.
METHODS
Study Sample
Participating GCCN clinics (n=95) were contacted and
access to the following data was requested for the 2013
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Table 1 provides descriptive statistics from all participating clinics, and Table 2 provides descriptive statistics for the n=1661
hypertensive patients visiting the 12 GCCN clinics.
Table 1. Descriptive Statistics of Data Received from Clinics
# of Patient Visits i n
# of Clinics
# of Patients in 2013
2013
(range)
(range)
Mean: 2114
48
Median: 782
(128-12502)
Mean: 6847
50
Median: 4123
(306-32122)

2013 Operating Costs
(range)

2013 Costs/Visit
(range)

Mean: 438,971
Median: 283,429
(41523-2.9 million)

Mean: 88
Median: 70
(9.37-313.90)

18

Table 2. Descriptive Statistics for the Hypertensive Patients from N=12 Clinics
# of Hypertension
Patients
Mean: 138.42
Range: 49-283
Total: 1661 patients

# of Hypertension
Visits/Year (from n=4
clinics only)
Mean: 5.5
Median: 5
Range: 2-25

Initial Blood Pressure
Systolic
Diastolic
147.9

The perspective of this analysis was that of the healthcare
system; that is, expenditures and avoided costs were those
accrued by the healthcare system only (regardless of payer).
The study period was one year, making discounting of costs
unnecessary. All costs were inflated to 2013 US dollars
using the medical component of the consumer price index
(US Department of Labor, 2014).

Systolic

Diastolic

137.71

84.49

Because the OASIS database does not differentiate by type
of stroke, both ischemic and hemorrhagic events were
included in the definition of stroke, as did Song et al.
(2013). For a baseline annual incidence of stroke, 3.2 per
1000 person-years was used, which is equal to the 2013 rate
of hospital discharges and deaths for stroke in persons aged
50-59, including all races and genders. This estimate is
similar to other estimates used previously, including that by
Song et al. (2013), which was 3.3 per 1000 person-years.

Analysis of Coronary Heart Disease (CHD) and Stroke
Events and Costs Averted
Following the methodology outlined by Song et al. (2013),
who estimated the cost savings of hypertension screening in
mobile clinics, the reductions in the risk of CHD events and
stroke that result from reductions in blood pressure were
examined. To determine the incidence of a CHD event in
Georgia for a hypertensive patient, rates from Georgia’s
Online Analytic Statistical Information System (OASIS)
database (Georgia Department of Public Health, 2015) were
used for diagnoses of high blood pressure, hypertensive
heart disease, obstructive heart disease including heart
attack, and aortic aneurism. As a proxy for CHD incidence,
because these data were not available otherwise, the 2013
annual hospital discharge rates and death rates for the
aforementioned diagnoses were summed, resulting in an
estimate of 7.9 cases of CHD per 1000 person-years for ages
50-59 years, including all races and genders. Song et al.
(2013) used a CHD incidence of 11.4 per 1000 personyears, which was incorporated into the sensitivity analysis.
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Follow-up Blood Pressure at 12 Mos.

To estimate the proportion of CHD and stroke events that
could be prevented with management of hypertension, the
results of a meta-analysis by Law et al. (2009), which were
also incorporated into the study by Song et al. (2013), were
used. The regression coefficients for the meta-analysis were
based on studies of blood pressure measured at baseline
with a minimum follow-up of 6 months. Data on blood
pressure change are from the sample of n=1661 patients at
the 12 clinics (Table 2). Following Song et al. (2013), these
reductions should have been adjusted for age, race, sex, and
comorbidity status. However, we used unadjusted estimates,
as these patient-level attributes were not available for this
sample. With the equations below, the relative risk
reductions for CHD and stroke events resulting from
hypertension management and treatment were estimated.
These risk reductions were then applied to the clinic
population to estimate the number of CHD and stroke
events averted.
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CHD Events

on average 5.5 times in the year. The average cost for a
GCCN visit, as estimated in Table 1, was $88. However,
because this mean was influenced by outliers, we eliminated
all cost per visit values that were +/- 3 standard deviation
points from the mean, thus eliminating n=1 cost per clinic
value ($314/visit). The adjusted mean was $75 per visit.

Stroke Events

The cost-savings summary measures included are common
in the field of economic evaluation, including net-benefits
(NBs), the benefit-cost (BC) ratio, and return on investment
(ROI) (Haddix et al., 2003). NBs are calculated by
subtracting expenditures of a program from an estimate of
its monetary benefits or savings. An NB result >0 suggests
that there is an economic rationale for funding a program.
BC ratios are calculated by dividing a program’s benefits or
savings by its expenditures. A BC ratio >1 suggests that
there is an economic rationale for funding a program.
Finally, ROI is calculated by dividing a program’s estimate
of NB by its expenditures. Like the NB measure, an ROI >0
reflects an economic incentive for funding a program.

To apply unit costs to CHD and stroke events averted,
estimates from the Coronary Heart Disease Policy Model
were used. This is a validated model that has been used for
over two decades to assess effects and costs of different
CHD prevention and treatment strategies (Moran et al.,
2015; Weinstein et al., 1987). For each CHD event, the
costs of fatal and not-fatal hospitalizations from acute
myocardial infarction plus 1-year follow-up costs ($44,000
for non-fatal and $46,000 for fatal, in 2010 US$) were used.
These costs were inflated to 2013 US$ and weighted to
reflect the data on incidence of fatal and not-fatal CHD
events from Georgia’s OASIS data (14% and 86%,
respectively), yielding a final estimate of $53,377. For each
stroke event, hospitalization and one-year follow-up costs
for fatal and not-fatal strokes ($37,000 for non-fatal stroke
and $26,000 for fatal strokes, in 2010 US$) were used.
These costs were weighted to reflect the data on incidence
of fatal and not-fatal strokes from Georgia’s OASIS data
(8% and 92%, respectively), thus equaling $39,437 (2013
US$).

RESULTS
For the 1661 patients in the sample, the reductions in
systolic and diastolic blood pressure were associated with a
32.0% reduction in CHD events and a 44.3% reduction in
strokes. Using the unit cost per case averted, the reduction
in incidence was estimated to save $318,832 from blood
pressure reductions over the one-year study period for the
1661 hypertensive patients in the sample (Table 3).

Analysis of ED Utilization and Costs Averted
Following the methodology of Song et al. (2013), how
GCCN hypertension management reduced ED utilization
and costs was also considered. Following Bicki et al.
(2012), the assumption was that 49%, or n=814, of the
initial hypertension visits resulted in an avoided ED visit.
For the sensitivity analysis, the assumption was that the
best-case scenario would be that 78% of first-time clinic
visits resulted in an avoided ED visit, based on a small study
conducted in the Athens Nurses Clinic (personal
communication, August 26, 2015). In the worst-case
scenario, 34.5% of first-time ED visits were assumed to be
averted (Nadkarni & Philbrick, 2003). For the unit cost of
an ED visit, $951 was used. This was derived from data of
the Agency for Healthcare Research and Quality, 2008
Medical Expenditure Panel Survey showing expenditures
for an ED visit with no surgery=$821 (in 2008$) inflated
to 2013$ (Machlin & Chowdhury, 2011). For the worstcase scenario, $413 was used, the reported cost of an ED
visit for a sore throat and flu symptoms at Athens Regional
Medical Center, where a 40% discount was applied for
being uninsured (Georgia Health News, 2013).

With each avoidable ED visit costing an average of $951,
there was an estimated total savings of $774,114 from the
814 estimated ED visits avoided for the sample of 1661
patients. This means that, for every 100 patients who visit a
GCCN clinic annually, the healthcare system saves more
than $50,000 in avoided ED visits.
In 2013, GCCN savings were $1,092,946 for the sample of
1661 hypertension patients; GCCN expenditures for treating
these patients in the same period were $685,163 (Table 3).
The NBs were $407,783 and the BC ratio was 1.6 (Table 3).
The ROI calculation was slightly different in that it
compared NB divided by expenditures. For these results, the
ROI was 0.6, or a 60% return on investment.
With a sensitivity analysis, savings, expenditures, and costsavings for a best-case and worst-case scenario were
estimated. For the best-case scenario, all parameter
estimates in favor of GCCN, where available, were used; in
the worst-case scenario, all estimates against GCCN, where
available, were used. In the best-case scenario, benefits
exceeded costs by more than $1 million, and the ratio of
benefits to costs was 2.9 (Table 3). These results imply that,
for each $1 spent in the best-case scenario, savings were
$2.90, representing a 190% return on investment. In the
worst-case scenario, benefits did not exceed costs, and for
each $1 spent, savings were only $0.63, representing a 37%
loss on investment. However, these losses occurred only
when both ED visits avoided and ED unit costs were at their

Estimating Cost-Savings
Cost-savings were estimated by first summing the savings
associated with reduced CHD and stroke events and
reductions in ED utilization and then comparing these
savings to the GCCN expenditures for treating hypertensive
patients. From the data collected (Table 2), each
hypertension patient was estimated to have visited the clinic
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lowest estimates. When the percent of ED visits avoided
was varied (from 34.5% to 78%) without varying any other
parameter, the BC ratio rose to a favorable range of 1.26 to

2.26. When the cost of an ED visit was varied without
varying any other parameter, any ED unit cost >$450
resulted in a positive NB.

Table 3. Calculation of Return on Investment in the GCCN
Category
Baseline
Blood Pressure Reduction
CHD Avoided
Baseline annual incidence (per 1000)
7.9
Preventable fraction (percent)
32
CHD cases avoided for the sample
4.2
(n=1661)
$53,377
Total CHD cost per case
$224,183
Total CHD costs avoided
Stroke Avoided
3.2
Baseline annual incidence (per 1000)
44.3
Preventable fraction (percent)
Stroke cases avoided for the sample
2.4
(n=1661)
Total stroke cost per case for 1-year follow-up

$39,437

Total stroke costs avoided
Total Savings from BP Reduction
ED Visits Avoided
Hypertension visits resulting in an avoided ED
visit (percent)

$94,649

Best Case

Worst Case

11.4

6

$320,262

$318,832

$414,911

49

78

34.5

# of initial hypertension visits to the ED that
would have occurred if not for the GCCN

814

1296

573

(for n=1661)
Cost per avoidable ED visit

$951

Total Savings from ED Visits Avoided
TOTAL SAVINGS

$413

$774,114

$1,232,496

$236,649

$1,092,946

$1,647,407

$555,481

5.5

5

6

9,135.50

8305

9966

GCCN Expenditures
# of hypertension visits per year
# of hypertension visits for the sample
(n=1661)
Cost per GCCN visit
Total GCCN Expenditures

$75

$68

$88

$685,163

$564,740

$877,008

NET BENEFITS (Savings - Expenditures)

$407,783

$1,082,667

-$321,527

1.6

2.9

0.63

BENEFIT-COST RATIO (Savings/Expenditures)
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data (n=12), it is also possible that these sites are not a
representative sample of all GCCN clinics and may manage
patients more or less efficiently than others in the network.

DISCUSSION
Management of hypertension in GCCN clinics indicates a
good investment in the base-case and the best-case
scenarios, based on the results of the cost-savings
calculations shown in Table 3. Considering a hypothetical
cohort of 100 patients receiving hypertension treatment in
GCCN clinics over the course of a year, the estimate is that
$13,500 and $5,700 will be saved from reductions in CHD
events and stroke, respectively, and $46,600 will be saved
due to fewer ED visits. When adjusted for the annual
expenditures to treat 100 patients annually in GCCN clinics
($41,250), the estimate is that for each $1 spent by GCCN
clinics, there is an average savings of $1.60. This represents
an annual savings of roughly $24,500 for each 100 patients
screened and treated for hypertension in GCCN clinics.

Implications for Public Health
Based on results of these analyses, there is economic
evidence to support investment in GCCN clinics across the
state for the screening and treatment of hypertensive
patients. Further, it is likely that the management of other
chronic conditions in GCCN clinics would provide similar
economic returns. For example, Fertig et al. (2012)
conducted a case study in which they estimated the benefits
and costs of a free clinic in Georgia providing general
primary care services. By use of matched data from the
clinic and its corresponding regional hospital on a sample of
newly enrolled clinic patients, the authors found that
patients’ non-urgent ED and inpatient costs at the hospital
fell by $170 per patient in the year following clinic
enrollment. After 3 years of sustained clinical management
of chronic diseases, they estimated that the savings from
reduced hospital utilization would offset clinic expenditures.
In another study, Zhou et al. (2014) found that among a
group of indigenous residents of Australia, primary care for
renal disease and diabetes was the most cost-effective
investment of clinical services, followed by hypertension
and ischemic heart disease.

Although the worst-case scenario does not produce a
favorable ROI, the economic returns are positive when key
model inputs are varied one at a time, rather than
simultaneously. Further, in comparison with other screening
and treatment options for hypertensive patients, the GCCN
may still represent a cost-effective option for managing
hypertension in the uninsured population. Prevention costs
money, and the money spent on prevention may well be
worth the money spent on treatment in the long-term.
Limitations
There are three major limitations to this analysis. First, we
used a healthcare system perspective, which is limited to
costs to the clinic and other healthcare providers. The
analysis does not include the costs of medications required
to manage hypertension, and, although these are not costs
that are realized by GCCN clinics, medications represent a
cost to some part of the healthcare system (even if they are
overstock and provided for “free” or reduced prices). From
a societal perspective, the costs of medications would have
been included, even if they were free to hypertension
patients frequenting GCCN clinics. Costs to patients would
also be included in the societal perspective, including any
healthcare costs paid out-of-pocket and losses
in
productivity associated with CHD and stroke events.
Second, since incidence rates for CHD events and stroke in
Georgia were not available, Georgia hospital discharge and
death rates were used. These were from the OASIS data
based on categories of disease that do not perfectly align
with the CHD definitions provided in Law et al. (2009) and
Song et al. (2013). The incidences of CHD and stroke are
likely higher in the South; however, the present estimates,
which are lower than those used by Song et al. (2013), do
not reflect that knowledge. Consequently, the estimates of
CHD and stroke events averted are likely to be conservative.

Despite the demonstrated positive ROI for screening and
treating hypertension in GCCN clinics and the likelihood of
greater economic impact from comprehensive GCCN
services, the network’s current patient capacity represents
only a small fraction of the uninsured. In 2013, 23% of
Georgians were uninsured, but GCCN clinics served only
8.5% of this population (Kaiser Family Foundation, 2014).
An efficient use of state resources may be to fund these
clinics in order to expand the population served and
consequently reduce uncompensated care costs for chronic
disease management and avoidable ED visits.
Although increased funding is essential to reach these goals,
expanding the reach of free and charitable clinics in Georgia
will necessitate more than financial support. First, an
efficient and directed expansion will require collection and
analysis of high-quality data including descriptions of the
demographics, clinical profiles, and health needs of the
patient population. Second, improvements in technology
and infrastructure may be needed to boost the care capacity
of existing clinics. Finally, expansion will require volunteer
hours from additional medical and administrative personnel
needed to staff these clinics. Addressing these hurdles and
extending the reach of GCCN clinics has the potential to
provide cost-savings to the health system through costefficient identification, treatment, and management of
chronic diseases and to reduce the adverse health outcomes
associated with being uninsured for Georgia’s vulnerable
populations.

Third, all costs related to the initial identification of the
cohort of 1661 hypertensive patients were not included, as
each clinic likely served multiple patrons per hypertension
case identified. Since patient-level data were not available
for the entire clinic population, the analysis of costs and
benefits was limited to the treatment of the 1661 patients.
Given the small number of clinics providing patient-level
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338, b1665.
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settings, 2008 (Statistical Brief #318) [pdf document]. Agency
for Healthcare Research and Quality. Retrieved from
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Moran, A. E., Odden, M. C., Thanataveerat, A., Tzong, K. Y.,
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guidelines. N Engl J Med, 372(5), 447-455.
doi:10.1056/NEJMsa1406751
Nadkarni, M. M., & Philbrick, J. T. (2003). Free clinics and the
uninsured: The increasing demands of chronic illness. J Health
Care Poor Underserv, 14(2), 165-174.
Song, Z., Hill, C., Bennet, J., Vavasis, A., & Oriol, N. E. (2013).
Mobile clinic in Massachusetts associated with cost savings
from lowering blood pressure and emergency department use.
Health Aff (Millwood), 32(1), 36-44.
doi:10.1377/hlthaff.2011.1392
United States Department of Labor. (2014). Consumer Price Index.
Bureau of Labor Statistics. Retrieved from
http://www.bls.gov/cpi/
Weinstein, M. C., Coxson, P. G., Williams, L. W., Pass, T. M.,
Stason, W. B., & Goldman, L. (1987). Forecasting coronary
heart disease incidence, mortality, and cost: The Coronary Heart
Disease Policy Model. Am J Public Health, 77(11), 1417-1426.
Zhao, Y., Thomas, S.L., Guthridge, S.L., & Wakerman, J. (2014).
The cost-effectiveness of primary care for Indigenous
Australians with diabetes living in remote Northern Territory
communities. Med J Aust, 200(11), 658-662.

also offer preventive services and patient education to a
high-risk population lacking access to affordable primary
care. In states forgoing Medicaid expansion, free and
charitable clinics will continue to make up an important
part of the healthcare safety net, and providing these clinics
with sufficient resources for comprehensive disease
management is a more efficient and compassionate use of
funds than treating chronic disease crises in EDs or not at
all.
Acknowledgement
This study was supported by a grant from the HealthCare Georgia
Foundation and was approved by the Institutional Review Board at
the University of Georgia. We acknowledge the leadership and
generosity of Donna Looper, Director of the Georgia Charitable
Care Network (GCCN), for coordinating the data collection efforts
with the participating charitable and free clinics that affiliate with
GCCN.
References
Bailey, A. (2013, March 25). Misuse of emergency rooms: A
costly but avoidable error. Georgia Health News. Retrieved
from http://www.georgiahealthnews.com/2013/03/misuseemergency-rooms-costly-avoidable-error/
Bicki, A., Silva, A., Joseph, V., Handoko, R., Rico, S. V., Burns,
J., . . . De Groot, A. S. (2013). A nurse-run walk-in clinic: Costeffective alternative to non-urgent emergency department use by
the uninsured. J Community Health, 38(6), 1042-1049.
doi:10.1007/s10900-013-9712-y
Fertig, A. R., Corso, P.S., & Balasubramaniam, D. (2012). Benefits
and costs of a free community-based primary care clinic. J
Health Hum Serv Adm, 34(4), 456–470.
Georgia Department of Public Health, Office of Health Indicators
for Planning (OHIP). (2015). Online Analytical Statistical
Information System (OASIS), Mortality/Morbidity Web Query
Tool -- 2013 [data set]. Retrieved from http://oasis.state.ga.us/

GPHA www.jgpha.com

159

Georgia Public Health Association

